author-photo

Jeffrey S. Johnson

Bayer

10

Papers

370

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946).

2016 ChemMedChem
Show All
- Source
- Cite
- Save
Citations (56)
444 Novel 2,3-dihydroimidazo[1,2-c]quinazolines PI3K inhibitors: Discovery and SAR

2010 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Indanylacetic Acid Derivatives Carrying 4-Thiazolyl-phenoxy Tail Groups, a New Class of Potent PPAR α/γ/δ Pan Agonists: Synthesis, Structure−Activity Relationship, and In Vivo Efficacy

2007 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (47)
Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups—new classes of PPAR γ/δ and PPAR α/γ/δ agonists

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (5)
p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas

2001 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (40)
Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach.

2001 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (78)
Discovery of a new class of p38 kinase inhibitors

2000 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (44)
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors

2000 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (46)